Answers are grounded in this paper and cite their sources.
To the Editor: Brain-derived neurotrophic factor (BDNF) is associated with synaptic neuroplasticity and memory [1] and has been implicated in the pathophysiology of major depressive disorder (MDD) [2].According to our meta-analysis, blood levels (serum and plasma levels) of BDNF are lower in MDD patients than in healthy subjects [3] Conversely, treatment with antidepressants increased peripheral BDNF levels [4].We previously reported that serum BDNF levels in individuals who responded to paroxetine, significantly increased (2.6-fold) 8-weeks after treatment.This would suggest that paroxetine improved the depressive symptoms by increasing serum BDNF levels [5].
No takes yet. Share an insight, caveat, or question.
Yoshimura et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: